WebGenentech: Nina Malik, Medical Affairs Executive Director – CA Ecosystem MedPOINT Management: Kimberly Carey, President and Chief Executive Officer Pfizer: John D. Capretta, CMR, MBA, Regional Business Director Vituity: Theo Koury, MD, FACEP, President Liaison (non-voting) WebAug 1, 2024 · He joins IGM with more than 20 years of experience in cancer immunotherapy research and development, most recently as Vice President, Global Head of Cancer Immunotherapy Development at Genentech ...
Genentech CEO and key executive team Craft.co
WebMar 24, 2024 · Genentech to Present Data Across Broad and Impactful Neuroscience Portfolio at 2024 AAN Annual Meeting. ... Ph.D. chief medical officer and head of Global Product Development. “We remain committed to advancing the science and improving the lives of people living with neurological conditions.” ... WebDr. Rousseau most recently served as Executive Vice President, Head of Product Development, and Chief Medical Officer at Gritstone bio, where he was responsible for the company’s global clinical development strategies and expansion of its neoantigen-based immunotherapies. He led the buildout of the clinical development organization and ... ratio\u0027s 7x
Kim Gold - Chief Privacy Officer; Senior Associate …
WebLet's Break This Down: Q&A with Cameron James, PharmD, Medical Executive Director for Genentech’s Tennessee, Kentucky and West … WebApr 12, 2024 · Genentech Data Highlights Strength of Ophthalmology Portfolio and Commitment to Advancing Eye Care at ARVO 2024. ... Ph.D., chief medical officer and head of Global Product Development. “We are particularly encouraged by data indicating that Vabysmo may stabilize blood vessels and reduce fluid in the retina. Fluid control is … WebMar 2, 2024 · Feb 2006 - Jul 202412 years 6 months. Vice President, Global Head of Cancer Immunotherapy Development; Cancer Immunotherapy … dr rojko